- 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
- 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
- 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
- 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
- 如果EPS衰退,要觀察同業是不是有一樣的狀況
- 要留意增資減資和公司債對股本及EPS的影響
| 加權平均股數 QoQ YoY | EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | 營收 QoQ YoY | 毛利率(%) QoQ YoY | 營業利益率 QoQ YoY | 稅後淨利率 QoQ YoY | 營業利益 QoQ YoY | 稅後淨利 QoQ YoY | 稅前淨利率(%) QoQ YoY | 稅後淨利率(%) QoQ YoY | 兩季平均(YOY)營收成長率(%) | 兩季平均(YOY)EPS成長率(%) | 兩季平均(YOY)本業EPS成長率(%) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26Q1 (8) | 71 | 2.9 | 9.23 | -0.41 | 33.87 | 14.58 | -0.51 | 22.73 | 8.93 | -0.41 | 80.84 | 14.58 | 0.18 | 800.0 | 1700.0 | 56.00 | 210.58 | 131.08 | -190.79 | 91.99 | 94.5 | -153.26 | 92.94 | 94.32 | -0.35 | 27.08 | 10.26 | -0.29 | 32.56 | 6.45 | -153.26 | 92.94 | 94.32 | -153.26 | 92.94 | 94.32 | 375.00 | 4.93 | 0.26 |
| 25Q4 (7) | 69 | -2.82 | 13.11 | -0.62 | -24.0 | -148.0 | -0.66 | -22.22 | -112.9 | -2.14 | -38.96 | -37.18 | 0.02 | -50.0 | -80.0 | -50.64 | -349.21 | -189.01 | -2382.10 | -128.78 | -943.27 | -2170.18 | -124.75 | -1209.55 | -0.48 | -23.08 | -118.18 | -0.43 | -22.86 | -168.75 | -2170.18 | -124.75 | -1209.55 | -2170.18 | -124.75 | -1209.55 | -25.00 | -6.64 | -19.80 |
| 25Q3 (6) | 71 | 0.0 | 14.52 | -0.50 | 10.71 | 1.96 | -0.54 | -17.39 | -28.57 | -1.54 | -48.08 | -17.56 | 0.04 | 0.0 | -69.23 | 20.32 | 242.6 | -54.8 | -1041.21 | -10.65 | -319.5 | -965.61 | 12.63 | -269.37 | -0.39 | -14.71 | -25.81 | -0.35 | 10.26 | -9.38 | -965.61 | 12.63 | -269.37 | -965.61 | 12.63 | -269.37 | 150.00 | -2.98 | 0.23 |
| 25Q2 (5) | 71 | 9.23 | 14.52 | -0.56 | -16.67 | -33.33 | -0.46 | 17.86 | -4.55 | -1.04 | -116.67 | -30.0 | 0.04 | 300.0 | -20.0 | -14.25 | 92.09 | -213.46 | -941.00 | 72.88 | -54.38 | -1105.16 | 59.02 | -112.27 | -0.34 | 12.82 | -9.68 | -0.39 | -25.81 | -50.0 | -1105.16 | 59.02 | -112.27 | -1105.16 | 59.02 | -112.27 | - | - | 0.00 |
| 25Q1 (4) | 65 | 6.56 | 0.0 | -0.48 | -92.0 | 0.0 | -0.56 | -80.65 | 0.0 | -0.48 | 69.23 | 0.0 | 0.01 | -90.0 | 0.0 | -180.16 | -416.68 | 0.0 | -3470.29 | -1419.86 | 0.0 | -2696.86 | -1527.36 | 0.0 | -0.39 | -77.27 | 0.0 | -0.31 | -93.75 | 0.0 | -2696.86 | -1527.36 | 0.0 | -2696.86 | -1527.36 | 0.0 | - | - | 0.00 |
| 24Q4 (3) | 61 | -1.61 | 0.0 | -0.25 | 50.98 | 0.0 | -0.31 | 26.19 | 0.0 | -1.56 | -19.08 | 0.0 | 0.1 | -23.08 | 0.0 | 56.89 | 26.53 | 0.0 | -228.33 | 8.01 | 0.0 | -165.72 | 36.61 | 0.0 | -0.22 | 29.03 | 0.0 | -0.16 | 50.0 | 0.0 | -165.72 | 36.61 | 0.0 | -165.72 | 36.61 | 0.0 | - | - | 0.00 |
| 24Q3 (2) | 62 | 0.0 | 0.0 | -0.51 | -21.43 | 0.0 | -0.42 | 4.55 | 0.0 | -1.31 | -63.75 | 0.0 | 0.13 | 160.0 | 0.0 | 44.96 | 257.96 | 0.0 | -248.20 | 59.28 | 0.0 | -261.42 | 49.79 | 0.0 | -0.31 | 0.0 | 0.0 | -0.32 | -23.08 | 0.0 | -261.42 | 49.79 | 0.0 | -261.42 | 49.79 | 0.0 | - | - | 0.00 |
| 24Q2 (1) | 62 | 0.0 | 0.0 | -0.42 | 0.0 | 0.0 | -0.44 | 0.0 | 0.0 | -0.80 | 0.0 | 0.0 | 0.05 | 0.0 | 0.0 | 12.56 | 0.0 | 0.0 | -609.53 | 0.0 | 0.0 | -520.64 | 0.0 | 0.0 | -0.31 | 0.0 | 0.0 | -0.26 | 0.0 | 0.0 | -520.64 | 0.0 | 0.0 | -520.64 | 0.0 | 0.0 | - | - | 0.00 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/4 | 0.01 | -92.3 | 226.31 | 0.2 | 1191.6 | 0.19 | N/A | 本月係租賃及勞務收入增加;本年主係銷售醫療器材之收入增加所致 | ||
| 2026/3 | 0.17 | 2443.9 | 4171.96 | 0.18 | 1537.34 | 0.18 | 0.0 | 係銷售醫療器材之收入 | ||
| 2026/2 | 0.01 | 1.06 | 80.7 | 0.01 | 84.26 | 0.02 | 0.0 | 係租賃及勞務收入增加所致 | ||
| 2026/1 | 0.01 | -3.66 | 88.0 | 0.01 | 88.0 | 0.02 | 0.0 | 係租賃及勞務收入增加所致 | ||
| 2025/12 | 0.01 | 6.22 | -44.33 | 0.1 | -61.92 | 0.02 | 2.47 | 主係臨床前試驗勞務收入減少所致 | ||
| 2025/11 | 0.01 | -7.61 | 42.88 | 0.1 | -62.74 | 0.02 | 2.5 | 主係臨床前試驗勞務收入減少所致 | ||
| 2025/10 | 0.01 | 4.66 | -91.45 | 0.09 | -64.58 | 0.04 | 1.31 | 係臨床前試驗勞務收入減少所致 | ||
| 2025/9 | 0.01 | -72.94 | -84.76 | 0.08 | -52.21 | 0.04 | 1.34 | 係臨床前試驗勞務收入減少所致 | ||
| 2025/8 | 0.02 | 308.3 | 2571.73 | 0.08 | -41.56 | 0.05 | 1.09 | 係勞務收入增加所致 | ||
| 2025/7 | 0.01 | -60.42 | -92.56 | 0.05 | -59.71 | 0.04 | 1.31 | 係臨床前試驗勞務收入減少所致 | ||
| 2025/6 | 0.02 | -10.63 | -70.46 | 0.05 | -8.03 | 0.04 | 1.38 | 係臨床前試驗勞務收入減少所致 | ||
| 2025/5 | 0.02 | 326.56 | 0.0 | 0.03 | 0.0 | 0.02 | 2.0 | 本月係臨床前試驗勞務收入增加;本年係臨床前試驗勞務收入及租賃收入增加所致 | ||
| 2025/4 | 0.0 | 0.75 | 0.0 | 0.02 | 0.0 | 0.01 | 4.3 | 主係租賃收入增加所致 | ||
| 2025/3 | 0.0 | 7.6 | 0.0 | 0.01 | 0.0 | 0.0 | N/A | 主係租賃收入增加所致 | ||
| 2025/2 | 0.0 | 5.14 | 0.0 | 0.01 | 0.0 | 0.0 | N/A | 係租賃收入增加所致 | ||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A |
| 加權平均股數 YoY | EPS YoY | 本業EPS YoY | 營收 YoY | 毛利率(%) YoY | 營業利益率 YoY | 稅後淨利率 YoY | 營業利益 YoY | 稅前淨利 YoY | 稅後淨利 YoY | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 (5) | 69 | 13.11 | -2.14 | 0 | -2.23 | 0 | 0.1 | -64.29 | -26.61 | 0 | -1523.35 | 0 | -1430.14 | 0 | -1.6 | 0 | -1.5 | 0 | -1.48 | 0 |
| 2024 (4) | 61 | 8.93 | -1.56 | 0 | -1.52 | 0 | 0.28 | 27.27 | 35.17 | -33.15 | -402.77 | 0 | -355.84 | 0 | -1.11 | 0 | -0.98 | 0 | -0.95 | 0 |
| 2023 (3) | 56 | 0.0 | -1.17 | 0 | -1.03 | 0 | 0.22 | 10.0 | 52.61 | -37.72 | -339.96 | 0 | -309.44 | 0 | -0.76 | 0 | -0.7 | 0 | -0.66 | 0 |
| 2022 (2) | 56 | 21.74 | -1.13 | 0 | -1.08 | 0 | 0.2 | 0 | 84.47 | 0 | -389.71 | 0 | -325.30 | 0 | -0.76 | 0 | -0.64 | 0 | -0.64 | 0 |
| 2021 (1) | 46 | 35.29 | -1.80 | 0 | -1.17 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | -0.83 | 0 | -0.83 | 0 | -0.83 | 0 |
免責聲明
本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。